An intervention to decrease catheter-related bloodstream infections in the ICU
Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel, Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel
Abstract
Background: Catheter-related bloodstream infections occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
Methods: We conducted a collaborative cohort study predominantly in ICUs in Michigan. An evidence-based intervention was used to reduce the incidence of catheter-related bloodstream infections. Multilevel Poisson regression modeling was used to compare infection rates before, during, and up to 18 months after implementation of the study intervention. Rates of infection per 1000 catheter-days were measured at 3-month intervals, according to the guidelines of the National Nosocomial Infections Surveillance System.
Results: A total of 108 ICUs agreed to participate in the study, and 103 reported data. The analysis included 1981 ICU-months of data and 375,757 catheter-days. The median rate of catheter-related bloodstream infection per 1000 catheter-days decreased from 2.7 infections at baseline to 0 at 3 months after implementation of the study intervention (P< or =0.002), and the mean rate per 1000 catheter-days decreased from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (P<0.002). The regression model showed a significant decrease in infection rates from baseline, with incidence-rate ratios continuously decreasing from 0.62 (95% confidence interval [CI], 0.47 to 0.81) at 0 to 3 months after implementation of the intervention to 0.34 (95% CI, 0.23 to 0.50) at 16 to 18 months.
Conclusions: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Copyright 2006 Massachusetts Medical Society.
Source: PubMed
Próximos ensaios clínicos
-
Magnus MedicalCongressionally Directed Medical Research ProgramsRecrutamento
-
Nicholas ButowskiSiren BiotechnologyAinda não está recrutandoGlioma | Neoplasia Cerebral | Gliomas recorrentes de alto grauEstados Unidos
-
State University of New York at BuffaloAinda não está recrutandoEngajamento do pacienteEstados Unidos
-
Poitiers University HospitalAinda não está recrutando
-
Assistance Publique - Hôpitaux de ParisAinda não está recrutandoAnemia falciforme | Crise vaso-oclusiva
-
University of California, IrvineRecrutamentoCancer cerebral | Câncer do SNC | Câncer do Sistema Nervoso | Cancro Cerebral MetastáticoEstados Unidos
-
Qualia Life SciencesRecrutamento
-
Guangdong Raynovent Biotech Co., LtdAinda não está recrutando
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationRecrutamentoAdultos | Assistência Digital para Baixa Visão | Deficiências VisuaisHong Kong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Ainda não está recrutandoAdenocarcinoma Ductal Pancreático (PDAC)
-
Sun Yat-sen UniversityAinda não está recrutandoParar de fumar | Agente de IA | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityAinda não está recrutando